General Information of the Compound
Compound ID
CP0865019
Compound Name
9-Methoxy-4-(pyridin-3-ylmethyl)-7-(o-tolyl)-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine
    Show/Hide
Structure
Formula
C23H24N2O2
Molecular Weight
360.457
Canonical SMILES
COc1cc(-c2ccccc2C)cc2c1OCCN(Cc1cccnc1)C2
    Show/Hide
InChI
InChI=1S/C23H24N2O2/c1-17-6-3-4-8-21(17)19-12-20-16-25(15-18-7-5-9-24-14-18)10-11-27-23(20)22(13-19)26-2/h3-9,12-14H,10-11,15-16H2,1-2H3
    Show/Hide
InChIKey
FEPFEAVHCFDEQT-UHFFFAOYSA-N
Physicochemical Property
logP
4.46022
Rotatable Bonds
4
Heavy Atom Count
27
Polar Areas
34.59
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 122180266
ChEMBL ID
CHEMBL3586329
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00948, Prostaglandin E2 receptor EP2 subtype
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000516 ECV-304 Homo sapiens (Human)  1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS